Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

The French COVID-19 lockdown caused delays in diagnosing new melanoma cases, making them more severe.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Teletrichoscopy is a promising method for diagnosing hair disorders remotely during the COVID-19 pandemic.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

AGA might indicate higher risk for severe COVID-19.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Some early COVID-19 mutations in patients predicted future common virus mutations.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

Public interest in hair loss increased during the COVID-19 pandemic.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Frankincense may help treat COVID-19, but more research is needed.

Sex hormones may affect COVID-19 severity and outcomes.